WHO endorses fixed-dose triple combination HIV therapy

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.438, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy

By Milinkovic Ana   Mallolas Josep  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection

By Taylor Clare L   Wilkins Edmund GL  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Fixed-Dose Combination Therapy with Statins: Strengths, Limitations, and Clinical and Regulatory Considerations

By Hennekens Charles H.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 155-160

Adis International

Access to resources Recommend Favorite

Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone

By Bailey Clifford J   Green Brian D   Flatt Peter R  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 1017-1025

Informa Healthcare

Access to resources Recommend Favorite

Fixed-Dose Combination Lercanidipine/Enalapril

By Hair Philip I.   Scott Lesley J.   Perry Caroline M.  

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 95-106

Adis International

Access to resources Recommend Favorite